4Tomaschitz A, Ritz E, Pieske B, et al. Aldosterone and parathyroid hormone: a precarious couple for cardiovascular disease [J]. Cardiovasc Res, 2012, 94: 10- 19.
5Perk J, De Backer G, Gohlke H, et al. European guide- lines on cardiovascular disease prevention in clinical prac- tice (version 2012) : The Fifth Joint Task Force of the Eu- ropean Society of Cardiology and Other Societies on Cardio- vascular Disease Prevention in Clinical Practice (constitu- ted by representatives of nine societies and by invited ex- perts) [J]. Atherosclerosis, 2012, 223:1 -68.
6Murray TM, Rao LG, Divieti P, et al. Parathyroid hor- mone secretion and action: evidence for discrete receptors for the carboxyl-terminal region and related biological ac- tions of carboxyl-terminal ligands [ J ]. Endocr Rev, 2005, 26:78-113.
7Monego G, Arena V, Pasquini S, et al. Ischemic injury activates PTHrP and PTH1R expression in human ventricu- lar cardiomyocytes [ J]. Basic Res Cardiol, 2009, 104: 427 - 434.
8Iwata S, Walker MD, Di Tullio MR, et al. Aortic valve calcification in mild primary hyperparathyroidism [ J 1. J Clin Endocrinol Metab, 2012, 97 : 132 - 137.
9Osto E, Fallo F, Pelizzo MR, et al. Coronary microvascu- lar dysfunction induced by primary hyperparathyroidism is restored after parathyroidectomy [ J ]. Circulation, 2012, 126:1031 - 1039.
10Ogard CG, Engholm G, Almdal TP, et al. Increased mor- tality in patients hospitalized with primary hyperparathy- roidism during the period 1977 - 1993 in Denmark[ J]. World J Surg, 2004, 28 : 108 - 111.
